Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
CD Formulation has rich experience and superb technical strength in the field of biologics. Using our professional biopharmaceutical formulation platform, we are able to develop antibody tablets with high potency, safety and accessibility. Our goal is to provide superior solutions that meet our customers' specific needs and help advance the biologics industry.
The content of pharmaceutical ingredients in the tablets is accurate, which enables precise control of the dosage and is conducive to accurate treatment of diseases.
The pharmaceutical ingredients in tablets undergo compression, solidification and other processes during the manufacturing process, making the properties of the tablets more stable and ensuring the efficacy and safety of the drugs.
The tablets are small in size and light in weight, making them easy for patients to carry and take at any time.
The tablets can be taken directly with water, which is convenient to use and easy to master.
Compared with other dosage forms, the production cost of tablets is lower, which is conducive to lowering drug prices and reducing the financial burden on patients.
Before developing antibody tablets, our experts will conduct detailed communication with customers to clarify the disease targeted by the customer, the nature of the antibody, and evaluate whether the antibody has the potential to be developed into tablets.
We will collect relevant literature to understand the relevant properties, pharmacology, toxicology and other aspects of the antibody, and select appropriate excipients by referring to the literature.
Our experts will design a reasonable formula for your antibody based on literature research results, combined with factors such as dosage form selection, pharmacology and toxicology, including adjuvants, stabilizers or protectants, bacteriostatic agents, excipients, and flavoring agents, thinners, etc.
Based on the nature and formula design of the antibody, we will study a reasonable preparation process, including mixing, compression, drying and other links, determine the key process parameters, and optimize them.
After completing the preparation process study, we will evaluate the tablet dosage form, including appearance, hardness, disintegration time, release, stability, etc., to determine whether it meets the requirements.
Based on the formula design, preparation process and dosage form evaluation results, the quality standards of the tablets are formulated, including properties, identification, impurities, content and other indicators.
CD Formulation has a professional preclinical safety evaluation technology platform that can provide customers with services including acute toxicity testing, long-term toxicity testing, mutagenicity testing, reproductive toxicity testing and other services to determine the safety of tablets.
Our experts will design reasonable formulas for customers based on antibody properties, pharmacology, toxicology and other factors to ensure the effectiveness and safety of antibody tablets.
Every aspect of our antibody tablet development services has been carefully designed and carefully operated to ensure that the final antibody tablets provided are of high quality, safe and reliable.
Antibody tablets meet the needs of different patients. Compared with traditional injection dosage forms, we formulate antibodies into tablets, which has higher patient compliance and convenience.
CD Formulation focuses on the quality control of antibody drugs and has established a strict quality control system, covering the selection of raw materials, optimization of preparation processes, and testing of finished products.
Our cutting-edge antibody tablet development services combine scientific expertise, technical prowess and unwavering commitment to deliver exceptional, customer-focused solutions. If you are seeking breakthrough advances in antibody therapeutics or wish to explore the potential of antibody tablets, we invite you to contact us today.